You have 9 free searches left this month | for more free features.

chemotherapy-induced grade-4 thrombocytopenia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin Lymphoma Trial in Milano (Romiplostim)

Completed
  • Non-Hodgkin Lymphoma
  • Milano, Italy
    Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte T
Aug 10, 2022

Chemo-Induced Thrombocytopenia Trial (Hetrombopag)

Not yet recruiting
  • Chemotherapy-Induced Thrombocytopenia
  • (no location specified)
Jul 24, 2023

Chemo-induced Thrombocytopenia Trial (Hetrombopag)

Not yet recruiting
  • Chemotherapy-induced Thrombocytopenia
  • (no location specified)
Oct 20, 2023

Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)

Completed
  • Chemotherapy-induced Thrombocytopenia
  • Shanghai, Shanghai, China
    Shanghai East Hospital
May 5, 2023

Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

Not yet recruiting
  • Chemotherapy-Induced Thrombocytopenia
  • Hetrombopag Olamine
  • (no location specified)
Jul 5, 2023

Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Hetrombopag plus Placebo, Placebo)

Not yet recruiting
  • Chemotherapy-Induced Thrombocytopenia
  • (no location specified)
May 17, 2023

Chemo-induced Thrombocytopenia, Herombopag Trial in Tianjin (Herombopag)

Recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Herombopag
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023

Chemo-induced Thrombocytopenia, Avatrombopag Trial in Tianjin (Avatrombopag)

Recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Avatrombopag
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023

Chemo-induced Thrombocytopenia, Eltrombopag Trial in Tianjin (Eltrombopag)

Recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Eltrombopag
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023

Chemo-induced Thrombocytopenia (CIT) Trial in Chengdu (Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic

Recruiting
  • Chemotherapy-induced Thrombocytopenia (CIT)
  • Recombinant Human Tumor Necrosis Factor Receptor II -Fc-TPO Mimetic Peptide Fusion Protein
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jun 23, 2022

Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911, Placebo)

Recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Sep 21, 2022

Thrombocytopenia Trial in Hefei (Avatrombopag)

Completed
  • Thrombocytopenia
  • Hefei, Anhui, China
    Anhui Provincial Cancer Hospital
Apr 24, 2022

Breast Cancer Trial in Zhengzhou (Hetrombopag, rh-TPO)

Not yet recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
May 26, 2022

Gastrointestinal Cancer, Gastrointestinal Tumors, Chemo-Induced Thrombocytopenia Trial in Miami, Boston (Avatrombopag, Matching

Not yet recruiting
  • Gastrointestinal Cancer
  • +2 more
  • Miami, Florida
  • +1 more
Mar 6, 2023

Chemotherapy Solid Tumors Who Receiving Thrombocytopenia

Completed
  • Chemotherapy-induced Thrombocytopenia
  • Recombinant Human Interleukin-11 for Injection
  • Shenyang, Liaoning, China
    Xing Xiaojing
Jan 15, 2023

Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Matching )

Not yet recruiting
  • Chemotherapy-Induced Thrombocytopenia
  • (no location specified)
Feb 21, 2022

NSCLC Trial (herombopag olamine tablets)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • herombopag olamine tablets
  • (no location specified)
Feb 14, 2022

Genomics and COVID-19 Vaccine Adverse Events

Recruiting
  • Vaccine Adverse Reaction
  • COVID-19 vaccines
  • Vancouver, British Columbia, Canada
    British Columbia Children's Hospital Research Institute
Jun 24, 2022

Isolated Chemo-induced Thrombocytopenia Trial in United States (romiplostim)

Active, not recruiting
  • Isolated Chemotherapy-induced Thrombocytopenia
  • romiplostim
  • Basking Ridge, New Jersey
  • +5 more
Feb 1, 2022

Chemo-induced Thrombocytopenia Trial in Worldwide (Romiplostim, Placebo)

Recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Romiplostim
  • Placebo
  • Jonesboro, Arkansas
  • +114 more
Nov 11, 2022

Lymphoma Patients, Thrombocytopenia Trial in United States (Romiplostim)

Recruiting
  • Lymphoma Patients
  • Thrombocytopenia
  • Miami, Florida
  • +7 more
Feb 2, 2022

Chemo-induced Thrombocytopenia Trial in Worldwide (Romiplostim, Placebo)

Recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Jonesboro, Arkansas
  • +107 more
Feb 1, 2023

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Chemo-Induced Nausea and Vomiting (CINV) Trial in Canton (SUSTOL)

Recruiting
  • Chemotherapy-Induced Nausea and Vomiting (CINV)
  • Canton, Ohio
    Gabrail Cancer Center Research
Jul 15, 2022

Chemo-induced Thrombocytopenia Trial in Worldwide (Avatrombopag, Placebo Oral Tablet)

Active, not recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Anaheim, California
  • +54 more
Nov 22, 2021